Vijaya Diagnostic Centre’s latest acquisition follows similar moves by Dr Lal PathLabs and Metropolis Healthcare
SP Tulsian, sptulsian.com is negative on midcap PSU banking stocks for the February series. “In spite of good results likely to be posted by all the midcap PSU banking, I won’t really be entering into at these levels. I will probably wait for their prices to correct,” he adds.